GMM Pfaudler Limited’s Board of Directors has accepted the resignation of Group Chief Financial Officer, Mr. Alexander Poempner, effective November 4, 2026. Concurrently, the Board approved the appointment of Mr. Ankit Nayyar as the new Group CFO and Key Managerial Personnel, also effective November 4, 2026. Mr. Poempner will continue until December 31, 2026, to facilitate a smooth transition.
Executive Leadership Changes at GMM Pfaudler
GMM Pfaudler Limited announced significant changes in its senior financial leadership following a Board Meeting held on September 15, 2026. The Board has officially accepted the resignation of Mr. Alexander Poempner from his position as Group Chief Financial Officer (CFO) and Key Managerial Personnel (KMP).
Transition and New Appointment
Mr. Poempner’s resignation will be effective upon the conclusion of the Board Meeting where the unaudited financial results for the quarter and half-year ended September 30, 2026 (Q2 FY27) are approved, which is currently planned for November 4, 2026. He will remain with the company until December 31, 2026, to ensure an orderly handover and provide transition support.
In a parallel decision, the Board has approved the appointment of Mr. Ankit Nayyar as the new Group CFO and KMP, also effective from November 4, 2026. Mr. Nayyar brings extensive experience in financial leadership roles across various sectors.
Mr. Ankit Nayyar’s Profile
Mr. Nayyar joined GMM Pfaudler as Deputy CFO in May 2026. He possesses nearly two decades of experience in pharmaceuticals, specialty chemicals, manufacturing, and financial services. Previously, as CFO of PI Health Sciences, he managed global finance operations, M&A, deal structuring, and operational scaling. He was also instrumental in the Monsanto-Bayer integration, building finance capabilities and governance in India. Earlier, Mr. Nayyar held leadership positions at Pfizer and MSCI.
Source: BSE
